Off Patent
All months

Merck Sharp and Dohme LLC a sub of Merck and Co Inc

1 of its medicines loses its last listed patent or exclusivity between January 1, 2026 and December 31, 2027.

  1. Janumet XRmetformin hydrochloride and sitagliptin phosphate